© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
534219 |
As an accredited 4-Bromo-1H-Pyrazole-3-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-1H-Pyrazole-3-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry often feels both overwhelming and magical, especially when special intermediates bring big change in the lab. There’s one name that keeps popping up across pharmaceutical and fine chemical research: 4-Bromo-1H-Pyrazole-3-Carboxylic Acid. This compound, known for its unique structure, takes center stage in many synthetic strategies. The story isn’t just about a molecule with a catchy name. It’s about why researchers keep reaching for it, how it impacts new discoveries, and what makes it stand out from its close cousins in the world of heterocyclic building blocks.
4-Bromo-1H-pyrazole-3-carboxylic acid holds its own as a pyrazole derivative. With a bromine atom at the 4-position and a carboxylic acid at the 3-position, the molecule opens doors for downstream functionalization. The molecular formula, C4H3BrN2O2, translates to a moderate molecular weight that suits it for scale-up in both laboratory and industrial settings. Chemists see immediate opportunities with this structure: ease of derivatization, selective substitution, and compatibility across a range of organic reactions.
The purity of this compound often ranges above 95%, giving peace of mind to those who rely on clean starting materials for reproducible reactions. The solid form, usually a white to off-white crystalline powder, dissolves efficiently in polar solvents like DMSO and DMF, yet resists breaking down in water, which helps in purification steps and storage. Melting points usually land between 160°C and 180°C, giving another layer of confirmation to anyone verifying the material in their inventory.
People sometimes wonder why particular chemicals matter so much to discovery. I notice this question pops up especially from friends working outside synthesis labs. The value of 4-Bromo-1H-pyrazole-3-carboxylic acid comes from its behavior as both a starting block and an actor in critical transformation steps. Medicinal chemists use it for constructing new drug candidates. The framework of the pyrazole ring shows up in kinase inhibitors, anti-inflammatory drugs, and antifungal agents. The bromine atom doesn’t just sit there either — it acts as a handle, ready for coupling reactions like Suzuki, Sonogashira, and Stille. Each of these tools gives chemists the freedom to swap bromine for complex aromatic rings or functional groups in pursuit of high-performance materials and potent pharmaceuticals.
Beyond the lab’s glassware, there’s a real-world impact. Pyrazole-based molecules built from this acid show up in agricultural products, where crop protection stands as a daily concern for big and small farmers alike. I’ve seen scientists use it as a stepping-stone for fluorescent probes and dyes in diagnostics. Special design starts with building blocks like this, and the decisions made in the lab ripple outwards to devices, therapies, and even the food that ends up on our tables.
Comparisons come easy in the world of heterocyclic acids. Yet, 4-Bromo-1H-pyrazole-3-carboxylic acid offers more than just a basic substitution. If you look at similar acids with other halogen substitutions—like chloro or fluoro analogs—you’ll notice changes in reactivity during cross-coupling and functionalization steps. Bromine strikes a good balance between leaving-group ability and stability, proving especially valuable in palladium-catalyzed couplings. Fluoro analogs may be less reactive in these reactions, pushing chemists toward harsher conditions or different catalysts. Chloro analogs sometimes give sluggish yields or require longer reaction times.
Even compared to the parent pyrazole-3-carboxylic acid, introducing bromine at the 4-position modernizes the chemistry. The aromatic ring becomes more programmable, welcoming nucleophilic substitutions and organometallic insertions. Some newer synthetic strategies hinge on this feature, creating room for rapid analog generation—an essential task in modern drug discovery and material design. With every round of optimization, scientists shave time off development cycles. That means new vaccines, electronic materials, and diagnostics reach people’s hands faster.
Walking through catalogs or digital inventory lists, you’ll see hundreds of building blocks. It takes experience to spot why 4-Bromo-1H-pyrazole-3-carboxylic acid gets singled out. Reliability jumps out first. Companies supplying it tend to meet strict analytical standards, supporting the push for traceability in regulated sectors. These standards aren’t just rule-following; they’re about lowering the risk of false starts in industrial projects. A big pharmaceutical team trusts documentation and batch data. Research startups need to cut costs and reruns. This compound’s track record supports both camps.
Ease of handling fits into the buying decision too. The typical solid form lets chemists weigh out accurate quantities fast, avoiding sticky messes or volatile losses. It’s stable enough for regular shipping and medium-term storage, freeing up budget for running reactions instead of paying for cold-chain logistics. The footprint also works with current environmental and safety norms. Few precautions go beyond the usual attention to glove and fume hood work common in synthetic labs.
Then there’s versatility: It serves as a bridge between medicinal chemistry, agrochemicals, and advanced material synthesis. In real terms, teams working on completely different goals grab the same jar from the shelf. That shared investment matters—the same base molecule underpins a new disease target and a pesticide that keeps crops safe. Synergy happens because the molecule is adaptable, not locked to one niche.
High-value research doesn’t just happen in the world’s biggest companies. Over the years, I’ve seen independent scientists, university labs, and startups transform ideas with surprisingly lean budgets. They rely on reliable access to building blocks, not vague promises. 4-Bromo-1H-pyrazole-3-carboxylic acid fills that gap. Transparency in supply chains, analytical paperwork, and purity reports matters just as much as molecular weight or melting point. One missing contamination, a wonky NMR, or even batch variability can derail entire projects.
Journals reporting clinical-stage compounds regularly cite pyrazole rings derived from this intermediate. Pharmaceutical filings sometimes list it or its analogs in their intellectual property claims. Rigorous academic groups submit spectral data, X-ray structures, and supplementary details confirming their syntheses started with off-the-shelf 4-Bromo-1H-pyrazole-3-carboxylic acid. This real-world evidence supports not only the product’s reliability but also its position as a recognized, traceable scaffold.
Research always comes with hurdles. Sourcing and repeatability sit high on the list for intermediates like this acid. The best labs build redundancy in their procurement and keep up relationships with a handful of trusted suppliers. Communication between chemists and procurement teams leads to shared expectations—batch size, purity thresholds, packaging, documentation.
Waste management and sustainability receive more attention every year. A team I worked with switched to using pyrazole intermediates with defined halogen substitution, including 4-Bromo-1H-pyrazole-3-carboxylic acid, to streamline reactions under greener protocols. Fewer byproducts emerged; recovery and purification steps became more manageable. This translated to fewer resources used—water, solvents, energy—at both bench and pilot scale. These changes often seem small day-to-day but add up over thousands of synthesis runs.
Finding enough material can feel like chasing shadows when project deadlines loom. Lead times for specialty intermediates sometimes stretch unpredictably. Teams combat this with advanced planning and by cataloging suppliers who demonstrate consistent stocks and honest lead time updates. Labs that maintain backup aliquots or split shipments across storage locations lose less time to disruptions. That flexibility helps both research and manufacturing keep pace, despite global supply chain swings.
One thing I’ve learned from years in chemical development—confidence comes from more than just a chemical’s purity certificate. Chemists look for clear analytical data: HPLC traces, NMR spectra, elemental analyses, and mass spec confirmations. Suppliers that include these with shipments remove stress for both research and quality assurance. Down the chain, unknown impurities or off-spec batches spell trouble during scale-up.
Batch-to-batch consistency matters in research, more so now that regulatory scrutiny is tightening. For actionable results, teams want every gram to reflect the exact same composition. Any drift prompts investigation and troubleshooting, stealing time and money from the core science. Suppliers specializing in high-purity pyrazole intermediates sustain confidence by publishing technical bulletins and open channels with technical experts. This culture of dialogue ensures everyone stays informed and aligned.
Sustainability takes real effort, beyond recycling flasks and minimizing solvent use. The trend to use intermediates like 4-Bromo-1H-pyrazole-3-carboxylic acid supports ongoing moves toward greener transformations. Teams revising laboratory procedures now prioritize higher yields and minimal waste. By using this acid in selective cross-coupling, fewer byproducts result. These improvements ripple down to less energy-intensive purification, lower solvent use, and leaner waste streams.
Suppliers now invest in greener syntheses and less hazardous reagents. Some evaluate water footprints and CO2 emissions tied to their supply chains. Customers—especially pharma and agrichemical groups—value partners that match their stewardship goals. The ripple effect continues down to audit trails, product stewardship, and packaging choices. Over time, modest gains in efficiency and waste reduction add up across entire sectors.
The boom in computational chemistry and automated synthesis platforms pushes demand for reliably sourced building blocks. 4-Bromo-1H-pyrazole-3-carboxylic acid finds itself at the crossroads, serving both traditional bench experiments and modern high-throughput platforms. Automated systems rely on compounds with sharp melting points and clean analytical profiles to automate dosing, mixing, and real-time tracking.
Material scientists blend this intermediate into screens for new polymers and optoelectronic materials, leveraging the pyrazole backbone’s electronic properties. The compound helps craft specialized ligands and sensors, not just small molecules for medical use. Those electrical and photonic properties stem from the unique electron distribution around the substituted pyrazole—where both the bromine and carboxylic acid play supporting roles.
Cross-disciplinary teams—encompassing chemists, pharmacologists, materials scientists, and engineers—find the commonality in this building block. The shared vocabulary and trusted compound simplify collaboration and data-sharing. A single well-understood intermediate can underpin multiple new products, streamlining R&D operations and making successful outcomes more likely.
Transitioning discoveries from lab to full-scale production takes thoughtful selection of intermediates. 4-Bromo-1H-pyrazole-3-carboxylic acid fits into this workflow not only through versatility, but through reliability under different scales. Pilot projects often test grams at the bench, then scale up to multi-kilogram batches for preclinical or field trials. Only robust, characterizable intermediates can keep up with that pace.
Supply-chain security stands front of mind for both established companies and startups. Shortages, contamination events, and packaging failures threaten long projects and investments. Sourcing from validated suppliers with transparent records—batch numbers, certificates, stability statements—means less downtime, fewer accidents, and more predictable results. A well-run supply chain keeps both the R&D floor and the production line humming.
Not every lab has the budget for specialty synthesis. Access to high-purity 4-Bromo-1H-pyrazole-3-carboxylic acid at smaller packaging sizes lowers the entry barrier for startups, academic research, and pilot innovators. Digital marketplaces and open catalogs break down access hurdles; more groups experiment and innovate, even with limited funds. Over the years, I’ve watched small, resourceful groups discover new reaction pathways or build entirely new product classes starting with just a few grams.
Shared protocols and published synthesis procedures for this acid improve reproducibility across different teams and time zones. Detail from peer-reviewed literature, with spectral data and reaction tips, helps new researchers avoid common missteps. The focus shifts from reinventing the same foundational chemistry to exploring new ideas and applications.
Drug discovery rarely stands still. As precision medicine evolves, so does the need for customizable and programmable intermediates. 4-Bromo-1H-pyrazole-3-carboxylic acid seems poised for yet more attention, particularly as the demands for selective kinase inhibitors, antiviral compounds, and anti-inflammatory agents continue to rise. Some emerging trends point to pyrazole derivatives in the development of brain-penetrant drugs and targeted therapies, where fine-tuning the physicochemical properties is essential.
Materials science keeps unlocking new value too. Conjugated polymers, organic field-effect transistors, and light-emitting materials all rely on building blocks capable of supporting electronic communication. The bromo- and carboxy-substituted pyrazole structure gives fertile ground for these advances, making it a mainstay for both established researchers and peers entering the field.
Despite strong uptake and widespread use, every chemical intermediate faces hurdles: supply interruptions, rising costs, and ever-tightening regulatory scrutiny. Shortage events can disrupt even well-oiled labs. Smarter inventory management, ties to reliable producers, and transparent price updates help soften the blow of these swings.
Communication helps solve problems before they escalate. In a world of globalized research, feedback loops between suppliers and customers, technical support, and post-purchase analytical help all make a difference. Chemists and research managers benefit from updates on upcoming compliance changes, revised safety data, and improvements in purification processes. For as long as I’ve been in science, success often comes down to relationships—knowing who to call, whom to trust, and how to solve hiccups without losing whole weeks of work.
Disposal procedures and handling protocols can always improve. As sustainability standards tighten, both large and small labs push for safer, greener, and more cost-effective waste management tied to specialty intermediates. Vendor partnerships in this area yield not just compliance, but real environmental progress over time.
No matter the final application—medicine, agriculture, materials—the need for robust and innovative starting materials remains constant. 4-Bromo-1H-pyrazole-3-carboxylic acid shines because it meets this need with its track record of reliability, flexibility, and accessibility. The real value lies not just in test tubes and patents, but in lives improved and challenges overcome. It’s a reminder that every breakthrough starts with a handful of well-chosen, well-understood building blocks, and that progress depends as much on quality and trust as on scientific imagination.
